Clinical trial
REACH Fostair vs Seretide - Real-world Effectiveness of Combination Therapies in Primary Care Asthma Management
NCT01908075 is registered in ClinicalTrials.gov with Research in Real-Life Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- REACH Fostair vs Seretide - Real-world Effectiveness of Combination Therapies in Primary Care Asthma Management
- Lead sponsor
- Research in Real-Life Ltd
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2011
- Completion date
- March 31, 2013
- Enrollment
- 194,723 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.